Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$4.71

-0.14 (-2.89%)

, WBA

Walgreens Boots Alliance

$84.63

-1.28 (-1.49%)

06:19
03/21/17
03/21
06:19
03/21/17
06:19

Deutsche says Rite Aid could fall 53% if Walgreens deal fails

Deutsche Bank analyst George Hill points out that according to recent media reports, the Federal Trade Commission still has issues with Walgreens Boots Alliance's (WBA) proposed acquisition of Rite Aid (RAD) as well as Fred's (FRED) as a buyer of divested stores. Should the deal fail to close, Walgreens shares have downside to the $73-$79 range, or up to 14%, Hill tells investors in a research note, citing his analysis. Rite Aid shares, the analyst suspects, could fall to $2.25 per share, or 53% from current levels, the analyst contends. He believes a key to Walgreens' decision to certify compliance with the second request could be the current makeup of the FTC, which has three vacant seats along with a Democratic Commissioner and Republican Chairperson. Hill has a Buy rating on Walgreens with a $92 price target, which he notes excludes Rite Aid.

RAD

Rite Aid

$4.71

-0.14 (-2.89%)

WBA

Walgreens Boots Alliance

$84.63

-1.28 (-1.49%)

FRED

Fred's

$14.66

-0.54 (-3.55%)

  • 05

    Apr

  • 06

    Apr

RAD Rite Aid
$4.71

-0.14 (-2.89%)

01/17/17
01/17/17
UPGRADE
Target $95

Outperform
AmerisourceBergen upgraded to Outperform at Leerink
As previously reported, Leerink analyst David Larsen upgraded AmerisourceBergen (ABC) to Outperform from Market Perform and raised his price target on the shares to $95 from $75. The analyst believes the odds of the Walgreens Boots Alliance (WBA)/Rite Aid (RAD) transaction going through have "increased substantially," and believes that the long-term partnership with Walgreens Boots Alliance will act as a positive driver for volumes. Long-term, Larsen believes that AmerisourceBergen will continue to benefit from growth in specialty, biosimilars, and generic launches, while recent commentary seems to indicate that generic deflation trends are moderating.
01/20/17
EVER
01/20/17
NO CHANGE
EVER
Rite Aid could trade to $3.50 or below if deal is not completed, says Evercore ISI
Evercore ISI analyst Ross Muken believes Rite Aid (RAD) could have "massive" downside and would likely trade to $3.50 or below if the acquisition by Walgreens Boots Alliance (WBA) were not completed. For Walgreens, Muken said, if the deal is not completed, it would be a modest negative given the synergy potential and time committed to deal closure, but he expects Walgreen not to sit on the capital for very long and would look for a combination of share repurchases and additional M&A in the not-too-distant future.
01/20/17
01/20/17
NO CHANGE

Rite Aid-Walgreens deal closing 'way more likely than not,' says Cowen
After a Bloomberg article said that the FTC is concerned about the sale of Rite Aid (RAD) stores to Fred's (FRED) as a remedy to concerns about Walgreens' (WBA) takeover deal, Cowen analyst Charles Rhyee said that the report could reflect a split staff at FTC and the losing side making some noise or it could be a public negotiating tactic. Given the various paths forward, including litigation, Rhyee still thinks it is "way more likely than not" that this deal will ultimately close and views the weakness in Walgreens shares as a buying opportunity.
01/30/17
LEER
01/30/17
NO CHANGE
LEER
Outperform
Walgreens Boots Alliance, Rite Aid transaction still in-process, says Leerink
Leerink analyst David Larsen notes that he has confirmed with Walgreens Boots Alliance (WBA) that the deal with Rite Aid (RAD) would only terminate if either party were to walk away, which would require a formal announcement. Therefore, the analyst believes "no news is good news," and that the transaction is still in-process and on track. He reiterates an Outperform rating on Walgreens Boots Alliance's shares.
WBA Walgreens Boots Alliance
$84.63

-1.28 (-1.49%)

02/06/17
ATLE
02/06/17
UPGRADE
ATLE
Overweight
Walgreens Boots upgraded to Overweight from Neutral at Atlantic Equities
FRED Fred's
$14.66

-0.54 (-3.55%)

01/06/17
01/06/17
UPGRADE
Target $17.5

Equal Weight
Fred's upgraded to Equal Weight after Rite Aid pact at Stephens
As previously reported, Stephens analyst Ben Bienvenu upgraded Fred's (FRED) to Equal Weight from Underweight citing the company's agreement to purchase 865 Rite Aid (RAD) stores from Walgreens (WBA), which he acknowledged "could be transformational longer term" if approved by the FTC. However, he also thinks the execution risk is very high in the near-term and notes that the retail pharmacy and discount retail industries are currently very competitive. Bienvenu raised his price target on Fred's shares to $17.50 from $7.
02/07/17
SIDC
02/07/17
UPGRADE
SIDC
Buy
Fred's upgraded to Buy from Neutral at Sidoti
02/07/17
02/07/17
UPGRADE

Buy
Follow-up: Fred's upgraded to Buy on valuation at Sidoti
As previously reported, Sidoti upgraded Fred's to Buy from Neutral. Analyst Gregory Pendy said the sharp pullback in shares provides a buying opportunity and maintained his $18 price target.

TODAY'S FREE FLY STORIES

18:25
03/27/17
03/27
18:25
03/27/17
18:25
Conference/Events
Federal Reserve Bank of Dallas President speaks on monetary policy »

Dallas Federal Reserve…

EEI

Ecology & Environment

$9.90

-0.1 (-1.00%)

18:19
03/27/17
03/27
18:19
03/27/17
18:19
Hot Stocks
Ecology & Environment board urges shareholders to vote for company's nominees »

Ecology and Environment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDLI

PDL BioPharma

$2.05

0.07 (3.54%)

18:16
03/27/17
03/27
18:16
03/27/17
18:16
Hot Stocks
PDL BioPharma CFO discloses purchase of 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:15
03/27/17
03/27
18:15
03/27/17
18:15
General news
Breaking General news story  »

Dallas Federal Reserve…

RAVN

Raven

$29.75

0.45 (1.54%)

18:14
03/27/17
03/27
18:14
03/27/17
18:14
Hot Stocks
Raven CEO says 'entering fiscal year 2018 from a position of strength' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

RAVN

Raven

$29.75

0.45 (1.54%)

18:12
03/27/17
03/27
18:12
03/27/17
18:12
Hot Stocks
Breaking Hot Stocks news story on Raven »

Raven sees FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

RAVN

Raven

$29.75

0.45 (1.54%)

18:11
03/27/17
03/27
18:11
03/27/17
18:11
Earnings
Raven reports Q4 EPS 12c, consensus 15c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

OREX

Orexigen

$4.13

0.15 (3.77%)

18:05
03/27/17
03/27
18:05
03/27/17
18:05
Hot Stocks
Orexigen, Bruno reach distribution agreement for Mysimba »

Orexigen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

HUN

Huntsman

$22.89

0.24 (1.06%)

18:01
03/27/17
03/27
18:01
03/27/17
18:01
Hot Stocks
Huntsman moves up after projecting Q1 adjusted EBITDA to rise YoY »

Shares of chemical maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

PFE

Pfizer

$34.18

0.18 (0.53%)

, BMY

Bristol-Myers

$56.04

0.15 (0.27%)

18:00
03/27/17
03/27
18:00
03/27/17
18:00
Hot Stocks
Credit Suisse analysis shows value in hypothetical Pfizer-Bristol merger »

Credit Suisse analysts…

PFE

Pfizer

$34.18

0.18 (0.53%)

BMY

Bristol-Myers

$56.04

0.15 (0.27%)

NVS

Novartis

$75.10

0.73 (0.98%)

GILD

Gilead

$67.50

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 01

    Apr

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 06

    Jun

  • 26

    Jun

  • 27

    Aug

VRX

Valeant

$10.81

0.06 (0.56%)

18:00
03/27/17
03/27
18:00
03/27/17
18:00
Periodicals
Ex-Valeant CEO Pearson sues company over unpaid compensation, WSJ says »

Former Valeant CEO Mike…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 24

    Aug

DGLY

Digital Ally

$4.60

0.49 (11.92%)

, TASR

Taser

$22.47

-0.03 (-0.13%)

17:54
03/27/17
03/27
17:54
03/27/17
17:54
Earnings
Digital Ally reports Q4 adjusted EPS (63c), two estimates (20c) »

Reports Q4 revenue…

DGLY

Digital Ally

$4.60

0.49 (11.92%)

TASR

Taser

$22.47

-0.03 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

AEM

Agnico Eagle

$44.64

0.81 (1.85%)

17:51
03/27/17
03/27
17:51
03/27/17
17:51
Syndicate
Agnico Eagle to sell approximately 5M shares to institutional investor »

Agnico Eagle Mines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

  • 28

    Apr

HUN

Huntsman

$22.89

0.24 (1.06%)

17:50
03/27/17
03/27
17:50
03/27/17
17:50
Hot Stocks
Huntsman sees Q1 adjusted EBITDA to exceed the $274M reported in 1Q16 »

Huntsman Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

SELB

Selecta Biosciences

$11.92

-0.12 (-1.00%)

, RHT

Red Hat

$82.20

-0.76 (-0.92%)

17:43
03/27/17
03/27
17:43
03/27/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SELB

Selecta Biosciences

$11.92

-0.12 (-1.00%)

RHT

Red Hat

$82.20

-0.76 (-0.92%)

SNX

SYNNEX

$118.32

1.38 (1.18%)

PSIX

Power Solutions

$6.40

0.07 (1.11%)

OCN

Ocwen

$4.89

0.08 (1.66%)

TSRO

Tesaro

$156.73

-3.27 (-2.04%)

DRI

Darden

$75.58

-1.13 (-1.47%)

FMSA

Fairmount Santrol

$6.74

-0.08 (-1.17%)

HCLP

Hi-Crush Partners

$15.40

0.05 (0.33%)

DECK

Deckers Brands

$56.51

0.23 (0.41%)

CYRX

Cryoport

$3.75

0.2219 (6.29%)

EVH

Evolent Health

$21.25

0.4 (1.92%)

STOR

STORE Capital

$23.46

-0.25 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 04

    Apr

  • 06

    Apr

  • 12

    Apr

  • 02

    May

  • 03

    May

  • 09

    May

  • 30

    Jun

ADHD

Alcobra

17:41
03/27/17
03/27
17:41
03/27/17
17:41
Hot Stocks
Brosh raises stake in Alcobra to 10.9% ahead of investor meeting »

Brosh Capital disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

PSIX

Power Solutions

$6.40

0.07 (1.11%)

17:33
03/27/17
03/27
17:33
03/27/17
17:33
Hot Stocks
Weichai America to invest $60M in Power Solutions »

Power Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RADA

RADA Electronic

$1.15

-0.04 (-3.36%)

17:32
03/27/17
03/27
17:32
03/27/17
17:32
Syndicate
Breaking Syndicate news story on RADA Electronic »

RADA Electronic files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$17.15

0.34 (2.02%)

17:29
03/27/17
03/27
17:29
03/27/17
17:29
Syndicate
Breaking Syndicate news story on iShares Silver Trust »

iShares Silver Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAU

iShares Gold Trust

$12.08

0.07 (0.58%)

17:28
03/27/17
03/27
17:28
03/27/17
17:28
Syndicate
Breaking Syndicate news story on iShares Gold Trust »

iShares Gold Trust files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GABC

German American Bancorp

$44.33

-0.33 (-0.74%)

17:25
03/27/17
03/27
17:25
03/27/17
17:25
Hot Stocks
German American Bancorp announces 3-for-2 stock split »

German American Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$0.95

0.2215 (30.34%)

17:18
03/27/17
03/27
17:18
03/27/17
17:18
Hot Stocks
Staffing 360 Solutions, board reject buy-out offer from Jackson Investment Group »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$15.40

-0.24 (-1.53%)

17:16
03/27/17
03/27
17:16
03/27/17
17:16
Hot Stocks
Breaking Hot Stocks news story on Canada Goose »

Adage Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$140.32

-0.02 (-0.01%)

, AAPL

Apple

$140.88

0.24 (0.17%)

17:14
03/27/17
03/27
17:14
03/27/17
17:14
Periodicals
Facebook hires Apple vet to lead Oculus hardware efforts, Bloomberg says »

Facebook (FB) has hired…

FB

Facebook

$140.32

-0.02 (-0.01%)

AAPL

Apple

$140.88

0.24 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

ISTR

Investar Holding

$22.15

0.1 (0.45%)

17:13
03/27/17
03/27
17:13
03/27/17
17:13
Hot Stocks
Breaking Hot Stocks news story on Investar Holding »

EJF Capital reports 6.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.